EMERGENT BIOSOLUTIONS INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $3,560,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. Everything on this page is grouped by the registrant's LDA id (304931), not by name.

Clients 1

EMERGENT BIOSOLUTIONS INC $3,560,000 6 filings

Reported by year 2 years

2026 $1,240,000 2 filings
2025 $2,320,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
Office of Natl Drug Control Policy (NDCP) 6
SENATE 6
White House Office 6

Recent filings 6 total

Q2

EMERGENT BIOSOLUTIONS INC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $510,000 expenses · posted Jul 14, 2026

View → Q1

EMERGENT BIOSOLUTIONS INC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $730,000 expenses · posted Apr 14, 2026

View → Q4

EMERGENT BIOSOLUTIONS INC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $430,000 expenses · posted Jan 16, 2026

View → Q3

EMERGENT BIOSOLUTIONS INC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $530,000 expenses · posted Oct 15, 2025

View → Q2

EMERGENT BIOSOLUTIONS INC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $440,000 expenses · posted Jul 16, 2025

View → Q1

EMERGENT BIOSOLUTIONS INC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $920,000 expenses · posted Apr 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.